Effects of T‑cadherin expression on B16F10 melanoma cells

Duan,Xin‑Suo; Lu,Jie; Ge,Zhi‑Hua; Xing,En‑Hong; Lu,Hai‑Tao; Sun,Li‑Xin

doi:10.3892/ol.2013.1164

Effects of T‑cadherin expression on B16F10 melanoma cells

Authors:
- Xin‑Suo Duan
- Jie Lu
- Zhi‑Hua Ge
- En‑Hong Xing
- Hai‑Tao Lu
- Li‑Xin Sun
View Affiliations

Affiliations: Department of Dermatology, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China, Department of Stomatology, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China, Central Laboratory, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China
Published online on: January 30, 2013 https://doi.org/10.3892/ol.2013.1164
Pages: 1205-1210

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Melanoma is one of the most deadly skin cancers. T‑cadherin is an atypical member of the cadherin superfamily as it lacks the transmembrane and cytoplasmic domains and is anchored to cell membranes through glycosylphosphatidylinositol (GPI) anchors. T‑cadherin downregulation is associated with a poorer prognosis in various carcinomas, such as lung, ovarian, cervical and prostate cancer, while in the majority of cancer cell lines, T‑cadherin re‑expression inhibits cell proliferation and invasiveness, increases susceptibility in apoptosis and reduces tumor growth in in vivo models. The functional relevance of T‑cadherin gene expression in melanoma progression remains to be clarified. The present study was designed for this purpose. The T‑cadherin gene was transfected into B16F10 melanoma cells to express T‑cadherin in the cells which were originally deficient in T‑cadherin expression. The proliferation, invasiveness, apoptosis and cell cycle of the transfected B16F10 melanoma cells were analyzed. The present study showed that the expression of T‑cadherin in B16F10 melanoma cells markedly reduced cell proliferation and permeation through Matrigel‑coated membranes, representing invasiveness. The percentage of early apoptotic cells and cells in the G2/M phase of the cell cycle was markedly increased compared with either parental B16F10 (without transfection) or empty pEGFP‑N1 (without T‑cadherin gene)‑transfected B16F10 cells, suggesting G2/M arrest, with similarity between the parental and empty pEGFP‑N1‑transfected B16F10 cells. T‑cadherin is important in melanoma progression and may be a possible target for therapy in melanoma and certain other types of cancer.

View Figures

View References

1	Erdei E and Torres SM: A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther. 10:1811–1823. 2010. View Article : Google Scholar
2	Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
3	Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, et al: A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 88:1484–1491. 2000. View Article : Google Scholar : PubMed/NCBI
4	Houghton AN and Polsky D: Focus on melanoma. Cancer Cell. 2:275–278. 2002. View Article : Google Scholar
5	Wheelock MJ and Johnson KR: Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol. 19:207–235. 2003. View Article : Google Scholar : PubMed/NCBI
6	van Roy F and Berx G: The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788. 2008.
7	Takeichi M: Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol. 5:806–811. 1993. View Article : Google Scholar : PubMed/NCBI
8	Christofori G and Semb H: The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 24:73–76. 1999. View Article : Google Scholar : PubMed/NCBI
9	Ranscht B and Dours-Zimmermann MT: T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron. 7:391–402. 1991. View Article : Google Scholar : PubMed/NCBI
10	Andreeva AV and Kutuzov MA: Cadherin 13 in cancer. Genes Chromosomes Cancer. 49:775–790. 2010.PubMed/NCBI
11	Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P and Resink TJ: A guide and guard: the many faces of T-cadherin. Cell Signal. 21:1035–1044. 2009. View Article : Google Scholar : PubMed/NCBI
12	Kuphal S, Martyn AC, Pedley J, Crowther LM, Bonazzi VF, Parsons PG, et al: H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res. 22:296–306. 2009. View Article : Google Scholar : PubMed/NCBI
13	Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y and Furihata M: Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett. 583:430–436. 2009. View Article : Google Scholar : PubMed/NCBI
14	Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zöchbauer-Müller S, et al: Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 61:8659–8663. 2001.PubMed/NCBI
15	Kawakami M, Staub J, Cliby W, Hartmann L, Smith DI and Shridhar V: Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol. 15:715–720. 1999.PubMed/NCBI
16	Ehrlich M, Woods CB, Yu MC, Dubeau L, Yang F, Campan M, et al: Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene. 25:2636–2645. 2006. View Article : Google Scholar : PubMed/NCBI
17	Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, et al: Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res. 61:4556–4560. 2001.PubMed/NCBI
18	Sato M, Mori Y, Sakurada A, Fujimura S and Horii A: The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet. 103:96–101. 1998. View Article : Google Scholar : PubMed/NCBI
19	Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, et al: DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 358:1118–1128. 2008. View Article : Google Scholar : PubMed/NCBI
20	Zhong Y, Delgado Y, Gomez J, Lee SW and Perez-Soler R: Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity. Clin Cancer Res. 7:1683–1687. 2001.PubMed/NCBI
21	Lee SW, Reimer CL, Campbell DB, Cheresh P, Duda RB and Kocher O: H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis. 19:1157–1159. 1998. View Article : Google Scholar : PubMed/NCBI
22	Chan DW, Lee JM, Chan PC and Ng IO: Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Int J Cancer. 123:1043–1052. 2008. View Article : Google Scholar : PubMed/NCBI
23	Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XF, et al: Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides. J Drug Target. 20:582–592. 2012. View Article : Google Scholar : PubMed/NCBI
24	Sun LX, Lin ZB, Li XJ, Li M, Lu J, Duan XS, et al: Promoting effects of Ganoderma lucidum polysaccharides on B16F10 cells to activate lymphocytes. Basic Clin Pharmacol Toxicol. 108:149–154. 2011.
25	Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XJ, et al: Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. J Pharm Pharmacol. 63:725–735. 2011. View Article : Google Scholar
26	Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Song YX, et al: Stronger cytotoxicity in CTLs with granzyme B and porforin was induced by Ganoderma lucidum polysaccharides acting on B16F10 cells. Biomed Prev Nutr. 2:113–118. 2012. View Article : Google Scholar
27	Hufbauer M, Lazić D, Reinartz M, Akgül B, Pfister H and Weissenborn SJ: Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets. J Dermatol Sci. 64:7–15. 2011. View Article : Google Scholar : PubMed/NCBI
28	Liang Y and Sundberg JP: SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes. J Dermatol Sci. 63:148–153. 2011. View Article : Google Scholar : PubMed/NCBI
29	Lai WW, Hsiao YP, Chung JG, Wei YH, Cheng YW and Yang JH: Synergistic phototoxic effects of glycolic acid in a human keratinocyte cell line (HaCaT). J Dermatol Sci. 64:191–198. 2011. View Article : Google Scholar : PubMed/NCBI
30	Chang SP, Shen SC, Lee WR, Yang LL and Chen YC: Imatinib mesylate induction of ROS-dependent apoptosis in melanoma B16F0 cells. J Dermatol Sci. 62:183–191. 2011. View Article : Google Scholar : PubMed/NCBI
31	Dong D, Jiang M, Xu X, Guan M, Wu J, Chen Q and Xiang L: The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro. J Dermatol Sci. 66:20–28. 2012. View Article : Google Scholar : PubMed/NCBI
32	Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, et al: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
33	Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
34	Wheelock MJ, Soler AP and Knudsen KA: Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia. 6:275–285. 2001. View Article : Google Scholar : PubMed/NCBI
35	Goodwin M and Yap AS: Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton. J Mol Histol. 35:839–844. 2004. View Article : Google Scholar : PubMed/NCBI
36	Drees F, Pokutta S, Yamada S, Nelson WJ and Weis WI: Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell. 123:903–915. 2005. View Article : Google Scholar : PubMed/NCBI
37	Doyle DD, Goings GE, Upshaw-Earley J, Page E, Ranscht B and Palfrey HC: T-cadherin is a major glycophosphoinositol-anchored protein associated with noncaveolar detergent-insoluble domains of the cardiac sarcolemma. J Biol Chem. 273:6937–6943. 1998. View Article : Google Scholar
38	Koller E and Ranscht B: Differential targeting of T- and N-cadherin in polarized epithelial cells. J Biol Chem. 271:30061–30067. 1996. View Article : Google Scholar : PubMed/NCBI
39	Philippova M, Ivanov D, Tkachuk V, Erne P and Resink TJ: Polarisation of T-cadherin to the leading edge of migrating vascular cells in vitro: a function in vascular cell motility? Histochem Cell Biol. 120:353–360. 2003. View Article : Google Scholar : PubMed/NCBI
40	Kinch MS, Petch L, Zhong C and Burridge K: E-cadherin engagement stimulates tyrosine phosphorylation. Cell Adhes Commun. 4:425–437. 1997. View Article : Google Scholar : PubMed/NCBI
41	Philippova MP, Bochkov VN, Stambolsky DV, Tkachuk VA and Resink TJ: T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett. 429:207–210. 1998. View Article : Google Scholar : PubMed/NCBI
42	Vestal DJ and Ranscht B: Glycosyl phosphatidylinositol-anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion. J Cell Biol. 119:451–461. 1992. View Article : Google Scholar : PubMed/NCBI
43	Dames SA, Bang E, Haüssinger D, Ahrens T, Engel J and Grzesiek S: Insights into the low adhesive capacity of human T-cadherin from the NMR structure of Its N-terminal extra-cellular domain. J Biol Chem. 283:23485–23495. 2008. View Article : Google Scholar : PubMed/NCBI
44	Takeuchi T and Ohtsuki Y: Recent progress in T-cadherin (CDH13, H-cadherin) research. Histol Histopathol. 16:1287–1293. 2001.PubMed/NCBI
45	Joshi MB, Philippova M, Ivanov D, Allenspach R, Erne P and Resink TJ: T-cadherin protects endothelial cells from oxidative stress-induced apoptosis. FASEB J. 19:1737–1739. 2005.PubMed/NCBI
46	Fredette BJ, Miller J and Ranscht B: Inhibition of motor axon growth by T-cadherin substrata. Development. 122:3163–3171. 1996.PubMed/NCBI
47	Rubina K, Sysoeva V, Semina E, Kalinina N, Yurlova E, Khlebnikova A and Molochkov V: Malignant transformation in skin is associated with the loss of T-cadherin expression in human keratinocytes and heterogeneity in T-cadherin expression in tumor vasculature. Tumor Angiogenesis. Ran S: InTech; New York, NY: pp. 135–166. 2012
48	Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med. 2:776–782. 1996. View Article : Google Scholar : PubMed/NCBI
49	Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, et al: Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res. 62:3382–3386. 2002.PubMed/NCBI